Conventional Antiarrhythmics Class I-IV, Late INa Inhibitors, IKs Enhancers, RyR2 Stabilizers, Gap Junction Modulators, Atrial-Selective Antiarrhythmics, and Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Therapy in Arrhythmias
Gender: Women have a lower body weight and water content
(2) GSH is a high-value product, with much previous effort focused on optimization of medium composition, culture conditions and genotype (e.g
The application of nano-agents in anti- Candida albicans therapy began in the 1990s, with the best-known products being AmB liposome
On the other hand, when only NAD+ is supported: Cells may produce energy more efficiently, but oxidative stress may still place a burden on them
Association between CYP 2C9 genetic variants and anticoagulation-related outcomes during warfarin treatment